MoneyWorks4Me

Aarti Drugs board to consider second interim dividend

25 Jan 2016 Evaluate

Aarti Drugs has informed that a meeting of the Board of Directors of the Company will be held on February 05, 2016, to consider, approve and take on record Audited Financial Results and Accounts for the quarter and nine months ended on December 31, 2015, and to consider declaration of 2nd Interim Dividend, if any.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..